These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 6514722)
1. Lipopolysaccharide of Legionella as adjuvant for intrinsic and extrinsic antigens. Wong KH; Feeley JC Proc Soc Exp Biol Med; 1984 Dec; 177(3):475-81. PubMed ID: 6514722 [TBL] [Abstract][Full Text] [Related]
2. Comparative adjuvant activities of Legionella pneumophila and Mycobacterium tuberculosis. McMaster PR; Tsang VC; Wong KH; Feeley JC; Gann DS Int Arch Allergy Appl Immunol; 1984; 73(4):357-62. PubMed ID: 6421749 [TBL] [Abstract][Full Text] [Related]
3. Induction of autoimmune diseases with adjuvants: separation of delayed hypersensitivity and antibody formation from diseases in experimental thyroiditis and aspermatogenesis with Legionella adjuvant. McMaster PR; Wong KH; Gardner JJ; Feeley JC; Rudofsky U Int Arch Allergy Appl Immunol; 1986; 80(1):1-8. PubMed ID: 3007368 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and adjuvanticity of lipopolysaccharide from Legionella pneumophila. Friedman H; Newton C; Blanchard DK; Klein TW; Widen R; Wong KH Proc Soc Exp Biol Med; 1987 Feb; 184(2):191-6. PubMed ID: 3809173 [TBL] [Abstract][Full Text] [Related]
5. Agar microdroplet assay for delayed hypersensitivity to Legionella pneumophila serogroup 1. Widen R; Klein T; Lee I; Friedman H J Clin Microbiol; 1983 May; 17(5):819-23. PubMed ID: 6863501 [TBL] [Abstract][Full Text] [Related]
6. Guinea pigs sublethally infected with aerosolized Legionella pneumophila develop humoral and cell-mediated immune responses and are protected against lethal aerosol challenge. A model for studying host defense against lung infections caused by intracellular pathogens. Breiman RF; Horwitz MA J Exp Med; 1987 Mar; 165(3):799-811. PubMed ID: 3819647 [TBL] [Abstract][Full Text] [Related]
7. Vaccination with the major secretory protein of Legionella induces humoral and cell-mediated immune responses and protective immunity across different serogroups of Legionella pneumophila and different species of Legionella. Blander SJ; Horwitz MA J Immunol; 1991 Jul; 147(1):285-91. PubMed ID: 1711078 [TBL] [Abstract][Full Text] [Related]
8. A live avirulent mutant Legionella pneumophila vaccine induces protective immunity against lethal aerosol challenge. Blander SJ; Breiman RF; Horwitz MA J Clin Invest; 1989 Mar; 83(3):810-5. PubMed ID: 2646318 [TBL] [Abstract][Full Text] [Related]
9. Legionella and the enterobacterial common antigen. LaScolea LS; Ambrus CM; Ambrus JL J Med; 1984; 15(5-6):437-40. PubMed ID: 6399522 [TBL] [Abstract][Full Text] [Related]
11. Serospecific antigens of Legionella pneumophila. Otten S; Iyer S; Johnson W; Montgomery R J Bacteriol; 1986 Sep; 167(3):893-904. PubMed ID: 3017918 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant action of bacterial lipopolysaccharide in induction of delayed-type hypersensitivity to protein antigens. II. Relationships of intensity of the action to that of other immunological activities. Ohta M; Nakashima I; Kato N Immunobiology; 1982 Dec; 163(5):460-9. PubMed ID: 6984417 [TBL] [Abstract][Full Text] [Related]
13. Serogroup specificity of Legionella pneumophila is related to lipopolysaccharide characteristics. Ciesielski CA; Blaser MJ; Wang WL Infect Immun; 1986 Feb; 51(2):397-404. PubMed ID: 2417953 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant action of bacterial lipopolysaccharide in induction of delayed-type hypersensitivity to protein antigens. Ohta M; Nakashima I; Kato N Cell Immunol; 1982 Jan; 66(1):111-20. PubMed ID: 7044560 [No Abstract] [Full Text] [Related]
15. Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. Blander SJ; Horwitz MA J Exp Med; 1989 Mar; 169(3):691-705. PubMed ID: 2926324 [TBL] [Abstract][Full Text] [Related]
16. The relationship between the serogroup antigen and lipopolysaccharide of Legionella pneumophila. Conlan JW; Ashworth LA J Hyg (Lond); 1986 Feb; 96(1):39-48. PubMed ID: 3950395 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Brucella abortus lipopolysaccharide as an adjuvant for tuberculin PPD. Jamalan M; Ardestani SK; Zeinali M; Mosaveri N; Mohammad Taheri M Biologicals; 2011 Jan; 39(1):23-8. PubMed ID: 20965746 [TBL] [Abstract][Full Text] [Related]
18. Antigens and toxic components of Legionella in pathogenesis and immunity. Wong KH; Feeley JC Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 255(1):132-7. PubMed ID: 6637227 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant activity of Klebsiella O3 lipopolysaccharide: no contribution of proteins to the expression of adjuvant activity. Kato N; Kido N; Ohta M; Naito S; Hasegawa T; Mori M; Agata N; Nakashima I; Kuno T Microbiol Immunol; 1983; 27(12):1043-55. PubMed ID: 6145085 [TBL] [Abstract][Full Text] [Related]
20. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin. Bomford R Clin Exp Immunol; 1980 Feb; 39(2):435-41. PubMed ID: 6248283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]